Laurence H. Beck Jr, MD, PhD
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Nephrology

MD, Harvard Medical School
PhD, Harvard University
BA, Princeton University



Laurence H. Beck, Jr., MD, PhD, completed his Internal Medicine residency and Nephrology fellowship at Boston Medical Center. He joined the Renal Section in 2006, and continues to conduct basic science research in the laboratory of Dr. David Salant on the pathogenesis of membranous nephropathy. His clinical roles include a weekly clinic and attending time on the consult and dialysis/transplant services. He also has expertise in immune-mediated glomerular disease.

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Graduate Medical Sciences Educator and Mentor (Primary Mentor of Graduate Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences





Investigating the functional capacity of autoantibodies in primary membranous nephropathy
09/20/2021 - 06/30/2025 (PI)
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
1R01DK126978-01A1

A PHASE 2, 12-WEEK, ADAPTIVE, OPEN LABEL, SEQUENTIAL COHORT TRIAL TO EVALUATE THE EFFICACY, …
10/17/2019 - 10/16/2024 (PI)
Pfizer, Inc


Redefining Membranous Nephropathy by Autoantibody-specific Subclassification
01/22/2013 - 12/31/2018 (PI)
NIH-NIDDK
1R01DK097053-03

Redifining Membranous Nephropathy by Autoantibody-specific Subclassification
01/22/2013 - 12/31/2018 (PI)
NIH-NIDDK
5R01DK097053-05

Investigation of Anti-PLA2R-Associated Membranous Nephropathy at the Molecular Level
09/01/2011 - 06/30/2013 (PI)
The Halpin Foundation

Detection of anti-phospholipase A2 receptor autoantibodies in idiopathic membranous nephropathy
07/01/2009 - 06/30/2013 (PI)
Amer Soc Nephrology

Identification of the endogenous antigen and development of an ELISA for the detection of autoantibo
07/01/2007 - 06/30/2013 (PI)
AMGEN, INC

Identification of the Endogenous Antigen and Development of an ELISA for the Detection of Autoantibo
07/01/2007 - 06/30/2009 (PI)
The Halpin Foundation


Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Urae S, Wang Z, Kumar S, Chen HA, Henderson JM, Beck LH, Borkan SC. Nucleophosmin (NPM) Promotes Regulated Cell Death in Podocyte Injury. Kidney360. 2025 Sep 16.View Related Profiles. PMID: 40956614; DOI: 10.34067/KID.0000000996;
     
  2. Al-Rabadi LF, Beck LH. The podocyte gets a pedicure: tiny nail clippers for podocyte foot processes. Kidney Int. 2025 Aug; 108(2):176-178. PMID: 40685177
     
  3. Wittig M, Verma A, Bellavia A, Rosan S, Claudel SE, Surapaneni A, Palsson R, Srivastava A, Stillman IE, Henderson JM, Beck LH, Hodgin JB, Grams ME, Rhee EP, Huber TB, Waikar SS, Schmidt IM. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression. Kidney360. 2025 Jul 29.View Related Profiles. PMID: 40728890; DOI: 10.34067/KID.0000000894;
     
  4. Beck L, De Sio C, Pritchard J, Hugtenburg RP, Li Y, Price T, Purves T, Flynn S, Velthuis JJ. Study of radiation damage of 28 MeV protons to the Lassena Monolithic Active Pixel Sensor. Appl Radiat Isot. 2025 Nov; 225:111921. PMID: 40543164
     
  5. Jeyabalan A, Czawlytko CL, Beck LH, Trivin-Avillach C. Case 10-2025: A 32-Year-Old Woman with Flank Pain, Fever, and Hypoxemia. N Engl J Med. 2025 Apr 10; 392(14):1428-1437. PMID: 40214035
     
  6. Avasare RS, Andeen NK, Al-Rabadi LF, Burfeind KG, Beck LH. Drug-Induced Membranous Nephropathy: Piecing Together Clues to Understand Disease Mechanisms. J Am Soc Nephrol. 2025 Apr 08; 36(8):1629-1638. PMID: 40198910; PMCID: PMC12342100; DOI: 10.1681/ASN.0000000719;
     
  7. Schmidt IM, Verma A, Claudel SE, Palsson R, Srivastava A, Stillman IE, Beck LH, Waikar SS. Genetic Testing in Biopsy-Confirmed Kidney Disease. Kidney Med. 2025 May; 7(5):100994.View Related Profiles. PMID: 40321977; PMCID: PMC12049994; DOI: 10.1016/j.xkme.2025.100994;
     
  8. Prunotto M, Nachman PH, Gillespie BS, Beck LH, Thompson AM, Hu AH, Stafford EA, Tarnoff JM, Rovin BH. Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy Workshop. Glomerular Dis. 2025; 5(1):133-141. PMID: 40092585; PMCID: PMC11908811; DOI: 10.1159/000544808;
     
  9. Prunotto M, Nachman PH, Gillespie BS, Beck LH, Thompson AM, Hu AH, Stafford EA, Tarnoff JM, Rovin BH. Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshop. Kidney Int. 2025 May; 107(5):809-815. PMID: 40088237
     
  10. Zee J, Hogan JJ, Abdullah A, Liu L, Kiryluk K, Beck LH. Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network. Clin J Am Soc Nephrol. 2025 May 01; 20(5):697-705. PMID: 40019793; PMCID: PMC12097183; DOI: 10.2215/CJN.0000000671;
     
Showing 10 of 120 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 120 publications over 22 distinct years, with a maximum of 14 publications in 2021

YearPublications
19903
19991
20001
20041
20081
20092
20103
20117
20128
20136
20147
20156
20168
20175
20184
20198
20205
202114
20226
20239
20244
202511

2019 American Society of Nephrology: Distinguished Researcher Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

anti-phospholipase A2 receptor autoantibodies
membranous nephropathy
PLA2R
Contact for Mentoring:

650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map


Beck's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department